comprehensive -WSS

comprehensive

author：comprehensive 2025-09-28 18:20:36 - browse：9

MultiPlan is facing a new class action lawsuit that alleges the company and large health insurers “conspired to fix, suppress, and stabilize” payments made for out-of-network medical claims.

The lawsuit, filed by for-profit hospital company Allegiance Health Management, builds on the contentious relationship between hospitals and MultiPlan, a data technology vendor that works with the biggest insurers to determine how much should be paid for care that is delivered outside of an insurance network. It comes just weeks after the New York Times published an investigation detailing how MultiPlan and its insurance company clients make more money by low-balling payments to hospitals.

The lawsuit further lays bare some of the warped incentives that exist within the health care system: out-of-network providers billing inflated amounts, insurers profiting by making sure those payments are as low as possible, and patients stuck in the middle with bills they often cannot afford.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Medicare Advantage today, explained in one chart

hotspot

WSS

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

FDA advisers back CAR

EPA limits use of carcinogenic gas for sterilizing medical devices

How digital therapeutics firms are pivoting after Pear's bankruptcy

Copay coupons to count toward deductibles, after Biden court move

focus

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

Continuity nursing helped my family in our darkest PICU moments

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

What does generative AI mean for health care? We asked experts

How digital therapeutics firms are pivoting after Pear's bankruptcy

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA clears AI tool for detecting skin cancer

Affirmative action in medical school literally saved lives

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

hotspot

How many hemophilia patients actually want gene therapy?

President Biden's budget: Here's what you might have missed

AI generated plenty of interest at JPM but not a lot of trust

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Why depression after traumatic brain injury is distinct

Boston's new lab space is opening empty

focus

hotspot

leisure time

knowledge